TABLE 2.

Clinical trial of polymyxin involved in drug resistance.

Status	ClinicalTrials.gov identifier	Condition or disease	Drug	Combination of drugs
Phase 3	NCT03159078	Trauma	Polymyxin B	Carbapenem
		Resistant Infection
		Critical Illness
Phase 3	NCT02134106	Bacteremia	Polymyxin B	Doripenem
		Healthcare-associated Pneumonia
		Ventilator-associated Pneumonia
Completed	NCT00753558	Carriage of Carbapemen-resistant Klebsiella pneumoniae	polymyxin E	Oral solution and buccal gel of gentamicin
Recruiting	NCT04839653	Respiratory Tract Infections	polymyxin B	Gentamycin, amphotericine B
		Critical Illness
Phase 4	NCT04489459	Blood Stream Infections Due to MDR Klebsiella pneumoniae	Colistin	Meropenem, Tigecycline
Completed	NCT01266499	Klebsiella Pneumoniae Carbapenemase Resistant Associated Bacteremia or Pneumonia	Colistin	Garamycin
Early Phase 1	NCT03950544	Antibiotic-Resistant Infection	Polymyxin B	Fosfomycin, Tigecycline
Recruiting	NCT04202861	Antibiotic Therapy	Polymyxins	Antibiotic combination
Phase 3	NCT05258851	Carbapenem-Resistant Enterobacteriaceae Infection	Colistin	Ceftazidime-avibactam
Phase 2	NCT02472600	Intestinal Colonization With MDR Bacteria	Colistin	Neomycin; Fecal microbiota transplantation; Omeprazole